Stock AMRUTANJAN AMRUTANJAN HEALTH CARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Amrutanjan Health Care Limited NSE India S.E.

Equities

AMRUTANJAN

INE098F01023

Pharmaceuticals

Delayed NSE India S.E.
Other stock markets
 04:57:49 05/10/2021 pm IST 		5-day change 1st Jan Change
828 INR +0.12% Intraday chart for Amrutanjan Health Care Limited -1.46% +64.69%
09/02 Amrutanjan Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
09/02 Amrutanjan Health Care Limited Declares Second Interim Dividend for the Financial Year 2023-24 CI

Valuation

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Capitalization 1 7,860 9,083 9,645 16,610 23,203 16,806
Enterprise Value (EV) 1 7,131 8,333 9,097 14,870 21,201 14,917
P/E ratio 39.4 x 37.1 x 38.5 x 27.2 x 34.5 x 42.2 x
Yield 0.73% 0.69% 0.33% 0.74% 0.58% 0.8%
Capitalization / Revenue 3.52 x 3.58 x 3.68 x 4.99 x 5.72 x 4.43 x
EV / Revenue 3.2 x 3.29 x 3.48 x 4.47 x 5.22 x 3.93 x
EV / EBITDA 24.4 x 25.7 x 29.8 x 19.9 x 25.5 x 32.5 x
EV / FCF 22.5 x 67.1 x 57 x 18.2 x 72.2 x 122 x
FCF Yield 4.44% 1.49% 1.75% 5.49% 1.38% 0.82%
Price to Book 6.11 x 6.23 x 6.05 x 7.71 x 8.75 x 5.78 x
Nbr of stocks (in thousands) 29,231 29,231 29,231 29,231 29,231 29,231
Reference price 2 268.9 310.8 330.0 568.2 793.8 575.0
Announcement Date 27/08/18 30/08/19 01/09/20 27/08/21 26/08/22 26/08/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net sales 1 2,232 2,535 2,617 3,330 4,059 3,798
EBITDA 1 292 324.2 304.9 747.3 830.5 458.7
EBIT 1 263.2 293.5 267.8 717.9 798.4 418.5
Operating Margin 11.79% 11.58% 10.23% 21.56% 19.67% 11.02%
Earnings before Tax (EBT) 1 329.6 351.7 344.5 819 905.8 536.5
Net income 1 199.7 245.1 250.8 611.9 671.9 398.3
Net margin 8.95% 9.67% 9.58% 18.37% 16.55% 10.49%
EPS 2 6.833 8.386 8.581 20.93 22.98 13.63
Free Cash Flow 1 316.3 124.1 159.6 816.5 293.5 122.7
FCF margin 14.17% 4.9% 6.1% 24.52% 7.23% 3.23%
FCF Conversion (EBITDA) 108.33% 38.29% 52.35% 109.26% 35.34% 26.75%
FCF Conversion (Net income) 158.36% 50.64% 63.63% 133.44% 43.68% 30.8%
Dividend per Share 2 1.950 2.150 1.100 4.200 4.600 4.600
Announcement Date 27/08/18 30/08/19 01/09/20 27/08/21 26/08/22 26/08/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 729 751 548 1,740 2,002 1,889
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 316 124 160 817 294 123
ROE (net income / shareholders' equity) 15.7% 18.2% 16.4% 32.6% 28% 14.3%
ROA (Net income/ Total Assets) 10% 10.4% 8.52% 18.7% 16% 7.35%
Assets 1 1,990 2,364 2,945 3,270 4,202 5,421
Book Value Per Share 2 44.00 49.90 54.50 73.70 90.70 99.50
Cash Flow per Share 2 10.00 4.990 2.470 0.9900 0.7500 1.680
Capex 1 30.6 20.4 25.4 19.6 235 89.3
Capex / Sales 1.37% 0.8% 0.97% 0.59% 5.78% 2.35%
Announcement Date 27/08/18 30/08/19 01/09/20 27/08/21 26/08/22 26/08/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+22.69% 43.81B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+25.22% 23.01B
SANDOZ GROUP AG Stock Sandoz Group AG
+18.00% 15.27B
CIPLA LIMITED Stock Cipla Limited
+8.91% 13.68B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+42.72% 11.96B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-7.25% 6.98B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+12.22% 5.59B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. AMRUTANJAN Stock
  4. AMRUTANJAN Stock
  5. Financials Amrutanjan Health Care Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW